14.89000 EUR
0.31
2.04%
Last update Dec 16, 8:00 AM CET
Main market
Day range
14.89000
14.89000
Previous close
15.20000
Open
14.89000
Access this stock data via API
Subscribe
Denali Therapeutics Inc.
14.89
0.31
2.04%

Statistics

Valuation metrics
Market cap
2.33B
Enterprise value
1.47B
Trailing P/E (ttm)
-5.73
Forward P/E
PEG ratio
Price/Sales (ttm)
Price/Book (mrq)
2.77
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.17
Overview
Shares outstanding
146.63M
Float
132.50M
Shares short
% Held by insiders
9.23%
% Held by institutions
92.78%
Average volume (10 days)
9
Average volume (90 days)
6
Price summary
52-Week low
10.28
52-Week high
22.52
52-Week change
-49.30 -479.6%
Beta
1.11
50-Day moving average
14.68
200-Day moving average
13.04
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
0
Operating margin
0
Operational effectiveness
Return on assets
-27.29%
Return on equity
-44.44%
Income statement
Revenue (ttm)
0
Revenue per share (ttm)
0
Quarterly revenue growth (yoy)
Gross profit (ttm)
-358.51M
EBITDA
-461.98M
Net income to common (ttm)
-425.05M
Diluted EPS (ttm)
-2.49
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
722.88M
Total cash per share (mrq)
5.78
Total debt (mrq)
37.91M
Total Debt/Equity (mrq)
4.80
Current ratio (mrq)
979.10%
Book value per share (mrq)
5.38
Cash flow
Cash flow statement
-339.01M
Levered free cash flow (LFCF)
-212.72M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 11 minutes

11:48
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).